NCT Number: NCT00433394
Registration and Informed Consent Study for the Childhood Cancer Research Network
RATIONALE: Collecting informed consent from parents of children with cancer to register with the Childhood Cancer Research Network may help the study of cancer in the future.
PURPOSE: This study is collecting informed consent to register younger patients with cancer into the Childhood Cancer Research Network.
Looking for future studies?
Notify MeKey information
Age range
Up to 20 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
University of Alberta Hospital, Edmonton, Alberta, Canada
About this study
OBJECTIVES:
- Obtain informed consent from parents (and the child, when appropriate) of children diagnosed with cancer (who are under 21 years of age) to register their child's name and address with the Childhood Cancer Research Network.
- Obtain informed consent from parents (and the child, when appropriate) of children diagnosed with cancer (who are under 21 years of age) to be contacted in the future for possible participation in non-therapeutic research studies involving the parents and/or child.
- Facilitate the systematic registration of pediatric and adolescent patients diagnosed with cancer into the Childhood Cancer Research Network.
OUTLINE: Consent is obtained from parents (and pediatric patients, where applicable) to register the patient's and parent's names and addresses with the Childhood Cancer Research Network, provide a copy of the pathology report to the Network, and contact parents in the future for possible non-therapeutic research studies involving the parents and/or child.
Information provided will be held in strict confidence.
PROJECTED ACCRUAL: Not specified
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Child (< 21 years of age) with newly diagnosed cancer
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
educational intervention
ProcedurePrimary outcomes
-
Informed consent collection to register with the Childhood Cancer Research Network
-
Informed consent collection for possible participation in future non-therapeutic research studies
-
Facilitation of systematic registration into the Childhood Cancer Research Network
Sponsors and collaborators
Lead sponsor
Children's Oncology Group
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Protocol for Registration and Consent to the Childhood Cancer Research Network - A Limited Institution Pilot
Important dates
- Study start
- 2001
- Primary completion
- 2007
- Study completion
- 2011
- First posted
- Feb 12, 2007
- Registry last updated
- Jun 27, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
NCT00638898
Adult Central Nervous System Germ Cell Tumor, Adult Rhabdomyosarcoma
Duarte, California, United States
View Trial DetailsIntensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases
NCT01586104
Adult Rhabdomyosarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Atlanta, Georgia, United States
View Trial DetailsTemozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
NCT00138216
Astrocytoma, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsAcupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
NCT01346267
Astrocytoma, Brain Diseases
Long Beach, California, United States
View Trial Details